ARWR
ARROWHEAD PHARMACEUTICALS, INC.
+2.44 (+3.71%)68.23USD1.4M成交股數9.6B市值–本益比(近四季)14.4股價營收比+171.0%營收年增(近四季)2026-11-24下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 1.2M · 2 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 3.1M |
| 近 180 天 淨額 | −3.1M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 08-20 | OLUKOTUN ADEOYE Y | Director | S 公開市場賣出 | 2.0K | 86.96 | 174K | 31.6K | SEC |
| 2026-08-18 | 08-20 | PERRY MICHAEL S | Director | S 公開市場賣出 | 11.6K | 87.30 | 1.0M | 111K | SEC |
| 2026-06-15 | 06-17 | Cohen Matthew Gregory | Director | A 獲配股票 | 11.9K | – | – | 11.9K | SEC |
| 2026-05-12 | 05-14 | Lu Hongbo | Director | S 公開市場賣出(10b5-1) | 3.0K | 76.88 | 228K | 52.0K | SEC |
| 2026-04-23 | 04-24 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 10.0K | 75.00 | 750K | 227K | SEC |
| 2026-04-22 | 04-24 | Apel Daniel Joseph | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.2K | 70.11 | 225K | 173K | SEC |
| 2026-04-22 | 04-24 | Apel Daniel Joseph | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.2K | 70.45 | 82K | 172K | SEC |
| 2026-04-22 | 04-24 | Apel Daniel Joseph | Chief Financial Officer | S 公開市場賣出(10b5-1) | 8.7K | 71.92 | 628K | 163K | SEC |
| 2026-03-05 | 03-09 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 10.0K | 64.19 | 642K | 237K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | G 贈與 | 540 | – | – | 473K | SEC |
| 2026-01-06 | 01-08 | Hamilton James C | Chief Medical Officer | A 獲配股票 | 75.0K | – | – | 247K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | G 贈與 | 440 | – | – | 472K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | G 贈與 | 540 | – | – | 474K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | G 贈與 | 540 | – | – | 474K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | A 獲配股票 | 75.0K | – | – | 547K | SEC |
| 2026-01-06 | 01-08 | Apel Daniel Joseph | Chief Financial Officer | A 獲配股票 | 75.0K | – | – | 176K | SEC |
| 2026-01-06 | 01-08 | O'Brien Patrick | COO | G 贈與 | 440 | – | – | 473K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 900 | 66.01 | 59K | 485K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 2.7K | 64.44 | 174K | 486K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 6.2K | 62.23 | 384K | 514K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 13.5K | 62.96 | 847K | 500K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 313 | 68.00 | 21K | 485K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 4.4K | 61.20 | 267K | 520K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 309 | 68.00 | 21K | 172K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 437 | 65.97 | 29K | 172K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.2K | 64.49 | 77K | 173K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 11.8K | 63.84 | 756K | 489K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 12.7K | 63.95 | 813K | 174K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 2.3K | 64.04 | 150K | 475K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 46 | 68.00 | 3K | 475K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.6K | 61.24 | 283K | 207K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 5.9K | 62.91 | 369K | 477K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 14.8K | 63.01 | 932K | 187K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 900 | 62.25 | 56K | 483K | SEC |
| 2026-01-05 | 01-05 | O'Brien Patrick | COO | S 公開市場賣出(10b5-1) | 600 | 61.12 | 37K | 484K | SEC |
| 2026-01-05 | 01-05 | Hamilton James C | Chief Medical Officer | S 公開市場賣出(10b5-1) | 6.1K | 62.28 | 379K | 201K | SEC |
| 2026-01-02 | 01-05 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.4K | 65.88 | 489K | 3.8M | SEC |
| 2026-01-02 | 01-05 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.8K | 66.39 | 383K | 3.8M | SEC |
| 2025-12-31 | 01-05 | O'Brien Patrick | COO | G 贈與 | 560 | – | – | 524K | SEC |
| 2025-12-31 | 01-05 | O'Brien Patrick | COO | G 贈與 | 560 | – | – | 527K | SEC |
| 2025-12-31 | 01-05 | O'Brien Patrick | COO | G 贈與 | 560 | – | – | 525K | SEC |
| 2025-12-31 | 01-05 | O'Brien Patrick | COO | G 贈與 | 560 | – | – | 526K | SEC |
| 2025-12-31 | 01-05 | O'Brien Patrick | COO | G 贈與 | 560 | – | – | 526K | SEC |
| 2025-12-29 | 12-30 | Anzalone Christopher Richard | Chief Executive Officer | M 選擇權執行 | 35.2K | 6.15 | 216K | 3.8M | SEC |
| 2025-12-29 | 12-30 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 16.5K | 68.69 | 1.1M | 3.8M | SEC |
| 2025-12-29 | 12-30 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 35.2K | 69.33 | 2.4M | 3.8M | SEC |
| 2025-12-29 | 12-30 | Anzalone Christopher Richard | Chief Executive Officer | M 選擇權執行 | 16.5K | 6.15 | 102K | 3.9M | SEC |
| 2025-12-26 | 12-30 | Ferrari Mauro | Director | S 公開市場賣出(10b5-1) | 7.5K | 70.00 | 527K | 69.1K | SEC |
| 2025-12-22 | 12-23 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 10.0K | 68.33 | 684K | 3.8M | SEC |
| 2025-12-22 | 12-23 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.6K | 68.85 | 177K | 3.8M | SEC |
| 2025-12-19 | 12-23 | Vakiener Victoria | Director | S 公開市場賣出(10b5-1) | 2.8K | 66.63 | 186K | 43.0K | SEC |
| 2025-12-19 | 12-23 | Vakiener Victoria | Director | S 公開市場賣出(10b5-1) | 5.3K | 67.97 | 359K | 37.7K | SEC |
| 2025-12-19 | 12-23 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 2.4K | 66.66 | 161K | 62.5K | SEC |
| 2025-12-19 | 12-23 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 500 | 68.53 | 34K | 56.6K | SEC |
| 2025-12-19 | 12-23 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 5.5K | 68.01 | 371K | 57.1K | SEC |
| 2025-12-19 | 12-23 | OLUKOTUN ADEOYE Y | Director | S 公開市場賣出(10b5-1) | 6.1K | 68.04 | 414K | 34.4K | SEC |
| 2025-12-19 | 12-23 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.3K | 68.48 | 90K | 3.8M | SEC |
| 2025-12-19 | 12-23 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 8.1K | 68.01 | 554K | 3.8M | SEC |
| 2025-12-19 | 12-23 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出(10b5-1) | 4.0K | 66.67 | 265K | 3.8M | SEC |
| 2025-12-19 | 12-23 | OLUKOTUN ADEOYE Y | Director | S 公開市場賣出(10b5-1) | 827 | 68.48 | 57K | 33.6K | SEC |
| 2025-12-19 | 12-23 | OLUKOTUN ADEOYE Y | Director | S 公開市場賣出(10b5-1) | 3.1K | 66.70 | 206K | 40.5K | SEC |
| 2025-12-19 | 12-23 | Vakiener Victoria | Director | S 公開市場賣出(10b5-1) | 2.0K | 68.39 | 134K | 35.7K | SEC |
| 2025-12-17 | 12-19 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 35.8K | 64.51 | 2.3M | 3.8M | SEC |
| 2025-12-17 | 12-19 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 46.3K | 63.55 | 2.9M | 3.9M | SEC |
| 2025-12-17 | 12-19 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 982 | 65.53 | 64K | 3.8M | SEC |
| 2025-12-17 | 12-19 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 2.0K | 66.30 | 131K | 3.8M | SEC |
| 2025-12-16 | 12-18 | INGRAM DOUGLAS S | Director | A 獲配股票 | 7.8K | – | – | 46.2K | SEC |
| 2025-12-16 | 12-18 | OLUKOTUN ADEOYE Y | Director | A 獲配股票 | 7.8K | – | – | 43.6K | SEC |
| 2025-12-16 | 12-18 | Vakiener Victoria | Director | A 獲配股票 | 7.8K | – | – | 45.8K | SEC |
| 2025-12-16 | 12-18 | Lu Hongbo | Director | A 獲配股票 | 7.8K | – | – | 55.0K | SEC |
| 2025-12-16 | 12-18 | PERRY MICHAEL S | Director | A 獲配股票 | 7.8K | – | – | 123K | SEC |
| 2025-12-16 | 12-18 | Waddill William D. | Director | A 獲配股票 | 7.8K | – | – | 64.9K | SEC |
| 2025-12-16 | 12-18 | Ferrari Mauro | Director | A 獲配股票 | 7.8K | – | – | 76.6K | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 14.1K | 62.12 | 876K | 3.9M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 11.0K | 61.25 | 671K | 4.0M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 8.4K | 60.51 | 509K | 4.0M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 8.5K | 62.94 | 533K | 3.9M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 6.7K | 64.29 | 428K | 3.9M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 1.0K | 64.96 | 65K | 3.9M | SEC |
| 2025-12-16 | 12-16 | Anzalone Christopher Richard | Chief Executive Officer | S 公開市場賣出 | 1.3K | 65.77 | 86K | 3.9M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 14.8M | 1.2B | 新進 | 新進 |
| Avoro Capital Advisors LLC | 11.4M | 926M | 新進 | 新進 |
| FMR LLC | 8.0M | 655M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.4M | 518M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | 498M | 新進 | 新進 |
| STATE STREET CORP | 5.7M | 464M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 3.9M | 318M | 新進 | 新進 |
| Invesco Ltd. | 3.9M | 317M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.5M | 299M | 新進 | 新進 |
| FRED ALGER MANAGEMENT, LLC | 3.3M | 269M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 2.0M | 162M | 新進 | 新進 |
| Siren, L.L.C. | 1.7M | 140M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.6M | 128M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.4M | 113M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 1.4M | 110M | 新進 | 新進 |
| Driehaus Capital Management LLC | 1.4M | 110M | 新進 | 新進 |
| Jupiter Topco LLC | 1.2M | 99.6M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.2M | 97.2M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.2M | 96.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.2M | 93.7M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.1M | 92.9M | 新進 | 新進 |
| Hood River Capital Management LLC | 1.1M | 91.4M | 新進 | 新進 |
| Holocene Advisors, LP | 1.1M | 90.2M | 新進 | 新進 |
| MORGAN STANLEY | 1.1M | 88.4M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 964K | 78.6M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 500 +62 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 500 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 120M · 84.6% |
| 合計季末市值 | 9.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.4M |
|---|---|
| 與上期比 | +2.4% |
| 佔流通股數 | 6.67% |
| 日均成交量 | 1.1M |
| 回補天數 | 8.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.4M | +2.4% | 6.67% | 1.1M | 8.8 |
| 2026-08-14 | 9.2M | -4.7% | 6.52% | 1.2M | 7.8 |
| 2026-07-31 | 9.7M | +0.2% | 6.84% | 2.5M | 3.9 |
| 2026-07-15 | 9.6M | +14.3% | 6.82% | 2.0M | 4.9 |
| 2026-06-30 | 8.4M | -28.2% | 5.97% | 3.8M | 2.2 |
| 2026-06-15 | 11.7M | -5.3% | 8.31% | 1.4M | 8.2 |
| 2026-05-29 | 12.4M | -4.1% | 8.77% | 1.5M | 8.3 |
| 2026-05-15 | 12.9M | -0.1% | 9.15% | 1.8M | 7.0 |
| 2026-04-30 | 12.9M | +7.7% | 9.16% | 1.9M | 6.7 |
| 2026-04-15 | 12.0M | -7.6% | 8.50% | 1.6M | 7.7 |
| 2026-03-31 | 13.0M | +13.8% | 9.21% | 2.4M | 5.4 |
| 2026-03-13 | 11.4M | +2.6% | 8.09% | 2.7M | 4.3 |
| 2026-02-27 | 11.1M | +3.0% | 7.89% | 1.9M | 5.9 |
| 2026-02-13 | 10.8M | -3.0% | 7.66% | 5.0M | 2.2 |
| 2026-01-30 | 11.2M | +3.3% | 7.89% | 2.0M | 5.7 |
| 2026-01-15 | 10.8M | +12.1% | 7.64% | 3.6M | 3.0 |
| 2025-12-31 | 9.6M | -5.9% | 6.81% | 1.8M | 5.3 |
| 2025-12-15 | 10.2M | -13.5% | 7.25% | 3.5M | 3.0 |
| 2025-11-28 | 11.8M | +2.1% | 8.38% | 3.4M | 3.4 |
| 2025-11-14 | 11.6M | -1.6% | 8.21% | 1.6M | 7.1 |
| 2025-10-31 | 11.8M | +1.2% | 8.34% | 1.7M | 6.8 |
| 2025-10-15 | 11.6M | -0.4% | 8.25% | 1.8M | 6.3 |
| 2025-09-30 | 11.7M | -1.4% | 8.28% | 2.5M | 4.8 |
| 2025-09-15 | 11.9M | -6.8% | 8.40% | 3.3M | 3.6 |
| 2025-08-29 | 12.7M | -2.0% | 9.01% | 2.3M | 5.6 |
| 2025-08-15 | 13.0M | +0.4% | 9.19% | 2.5M | 5.2 |